Development and validation of a MUC16 mutation-associated immune prognostic model for lung adenocarcinoma

Mucin 16 (MUC16) mutation ranks third among all common mutations in lung adenocarcinoma (LUAD), and it has a certain effect on LUAD development and prognostic outcome. This research aimed to analyze the effects of MUC16 mutation on LUAD immunophenotype regulation and determine the prognostic outcome...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Honggang, Xin, Tao, Duan, Hongtao, Wang, Yuanyong, Shao, Changjian, Zhu, Yifang, Wang, Jiansheng, He, Jianjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10333060/
https://www.ncbi.nlm.nih.gov/pubmed/37341998
http://dx.doi.org/10.18632/aging.204814

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10333060/
https://www.ncbi.nlm.nih.gov/pubmed/37341998
http://dx.doi.org/10.18632/aging.204814

Ejemplares similares